The potential of PARP as a therapeutic target across pediatric solid malignancies

BACKGROUND: Pediatric cancer is the leading cause of disease-related death in children and the need for better therapeutic options remains urgent. Due to the limited number of patients, target and drug development for pediatrics is often supplemented by data from studies focused on adult cancers. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Kaylee M., Koetsier, Joost, Schild, Linda, Amo-Addae, Vicky, Eising, Selma, van den Handel, Kim, Ober, Kimberley, Koopmans, Bianca, Essing, Anke, van den Boogaard, Marlinde L., Langenberg, Karin P. S., Jäger, Natalie, Kool, Marcel, Pfister, Stefan, Dolman, M. Emmy M., Molenaar, Jan J., van Hooff, Sander R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077757/
https://www.ncbi.nlm.nih.gov/pubmed/37020198
http://dx.doi.org/10.1186/s12885-022-10319-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077757/
https://www.ncbi.nlm.nih.gov/pubmed/37020198
http://dx.doi.org/10.1186/s12885-022-10319-7

Ejemplares similares